Free Trial
→ Wall Street legend reveals his top AI stock before Oct. 20 (From Chaikin Analytics) (Ad)tc pixel Free SDCCQ Stock Alerts

SmileDirectClub (SDCCQ) Competitors

Compare

SDCCQ vs. GMVDF, VRAYQ, TTOO, AFIB, and UTRS

Should you buy SmileDirectClub stock or one of its competitors? SmileDirectClub's main competitors and comparable companies include G Medical Innovations (GMVDF), ViewRay (VRAYQ), T2 Biosystems (TTOO), Acutus Medical (AFIB), and Minerva Surgical (UTRS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does SmileDirectClub compare to G Medical Innovations?

SmileDirectClub (NASDAQ:SDCCQ) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, media sentiment, institutional ownership, risk, valuation, profitability and dividends.

G Medical Innovations has lower revenue, but higher earnings than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A
G Medical Innovations$4.42M0.00-$24.63MN/AN/A

Company Net Margins Return on Equity Return on Assets
SmileDirectClubN/A N/A N/A
G Medical Innovations N/A N/A N/A

0.1% of SmileDirectClub shares are owned by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
SmileDirectClub Neutral
G Medical Innovations Neutral

SmileDirectClub has a beta of 1.35, suggesting that its stock price is 35% more volatile than the broader market. Comparatively, G Medical Innovations has a beta of 28.66, suggesting that its stock price is 2,766% more volatile than the broader market.

Summary

G Medical Innovations beats SmileDirectClub on 3 of the 5 factors compared between the two stocks.

How does SmileDirectClub compare to ViewRay?

ViewRay (NASDAQ:VRAYQ) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, media sentiment, analyst recommendations, risk, dividends and valuation.

ViewRay has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.35, meaning that its stock price is 35% more volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
ViewRayN/A N/A N/A
SmileDirectClub N/A N/A N/A

15.5% of ViewRay shares are owned by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are owned by institutional investors. 2.5% of ViewRay shares are owned by company insiders. Comparatively, 64.7% of SmileDirectClub shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, ViewRay's average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
ViewRay Neutral
SmileDirectClub Neutral

SmileDirectClub has higher revenue and earnings than ViewRay.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ViewRay$102.21M0.00-$107.33MN/AN/A
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A

Summary

SmileDirectClub beats ViewRay on 4 of the 6 factors compared between the two stocks.

How does SmileDirectClub compare to T2 Biosystems?

SmileDirectClub (NASDAQ:SDCCQ) and T2 Biosystems (NASDAQ:TTOO) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.

SmileDirectClub has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.

Company Net Margins Return on Equity Return on Assets
SmileDirectClubN/A N/A N/A
T2 Biosystems -563.16%N/A -174.06%

T2 Biosystems has lower revenue, but higher earnings than SmileDirectClub. T2 Biosystems is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A
T2 Biosystems$7.68M0.00-$50.08M-$3.89N/A

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled T2 Biosystems'average media sentiment score.

Company Overall Sentiment
SmileDirectClub Neutral
T2 Biosystems Neutral

SmileDirectClub has a beta of 1.35, indicating that its stock price is 35% more volatile than the broader market. Comparatively, T2 Biosystems has a beta of 8.13, indicating that its stock price is 713% more volatile than the broader market.

0.1% of SmileDirectClub shares are owned by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by insiders. Comparatively, 0.0% of T2 Biosystems shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

SmileDirectClub beats T2 Biosystems on 5 of the 9 factors compared between the two stocks.

How does SmileDirectClub compare to Acutus Medical?

SmileDirectClub (NASDAQ:SDCCQ) and Acutus Medical (NASDAQ:AFIB) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, valuation and profitability.

SmileDirectClub has a beta of 1.35, meaning that its stock price is 35% more volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.71, meaning that its stock price is 471% more volatile than the broader market.

SmileDirectClub has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. SmileDirectClub's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
SmileDirectClubN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
SmileDirectClub Neutral
Acutus Medical Neutral

Acutus Medical has lower revenue, but higher earnings than SmileDirectClub. Acutus Medical is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

0.1% of SmileDirectClub shares are owned by institutional investors. Comparatively, 56.9% of Acutus Medical shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by insiders. Comparatively, 5.2% of Acutus Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

SmileDirectClub beats Acutus Medical on 6 of the 10 factors compared between the two stocks.

How does SmileDirectClub compare to Minerva Surgical?

Minerva Surgical (NASDAQ:UTRS) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, valuation, media sentiment, earnings, risk, analyst recommendations and profitability.

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
SmileDirectClub N/A N/A N/A

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
SmileDirectClub Neutral

Minerva Surgical has higher earnings, but lower revenue than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A

Minerva Surgical has a beta of 2.37, indicating that its stock price is 137% more volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.35, indicating that its stock price is 35% more volatile than the broader market.

0.1% of SmileDirectClub shares are held by institutional investors. 8.5% of Minerva Surgical shares are held by company insiders. Comparatively, 64.7% of SmileDirectClub shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

SmileDirectClub beats Minerva Surgical on 4 of the 7 factors compared between the two stocks.

Get SmileDirectClub News Delivered to You Automatically

Sign up to receive the latest news and ratings for SDCCQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SDCCQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SDCCQ vs. The Competition

Export
MetricSmileDirectClubHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$40K$5.58B$7.26B$13.21B
Dividend YieldN/A1.75%2.52%22.89%
P/E Ratio0.0020.86206.6619.94
Price / SalesN/A67.32562.2181.34
Price / CashN/A32.2577.1653.04
Price / BookN/A5.8610.756.03
Net Income-$86.40M$146.14M$3.50B$380.34M

SmileDirectClub Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SDCCQ
SmileDirectClub
N/AN/AN/AN/A$40K$470.74MN/A2,700
GMVDF
G Medical Innovations
N/AN/AN/AN/A$26K$4.42MN/A84
VRAYQ
ViewRay
N/AN/AN/AN/A$16K$102.21MN/A295
TTOO
T2 Biosystems
N/A$0.00
+16.7%		N/A-88.6%$15K$7.68MN/A113
AFIB
Acutus Medical
N/AN/AN/A-80.0%$3K$7.16MN/A85

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SDCCQ) was last updated on 10/14/2026 by MarketBeat.com Staff.
From Our Partners
The AI Infrastructure Play Kevin O'Leary Is Backing
Kevin O'Leary became a strategic investor in a NASDAQ-listed AI infrastructure company, calling it essentially...
The Tomorrow Investor | Sponsoredtc pixel
Wall Street legend reveals his top AI stock before Oct. 20
Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...
Chaikin Analytics | Sponsoredtc pixel
Elon Musk’s One Stock Retirement Plan
Jeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...
Brownstone Research | Sponsoredtc pixel
AI Microcap Teams With Gentex on Next-Gen Military Helmets
Morgan Stanley projects the humanoid robotics market could reach $5 trillion by 2050, with more than 1 billion...
Capital Trends | Sponsoredtc pixel
My next big call (under $1)
The obvious way to "bet on Trump" in crypto is the Trump memecoin. And right now it's back in the news, with a...
Crypto 101 Media | Sponsoredtc pixel
Elon's next millionaires start October 24?
SpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...
Behind the Markets | Sponsoredtc pixel
Trump's about to unleash his Midterm Weapon
Trump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...
Monument Traders Alliance | Sponsoredtc pixel
How one AI fund pays investors every Thursday
One small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...
Investors Alley | Sponsoredtc pixel